A Phase 1/2, Open-Label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination with MEDI4736 and MEDI0680 Monotherapy in Subjects with Select Advanced Malignancies

  • Kwan, Edmond (Primary Chief Investigator (PCI))

Project: Other

Project Details

Project Description

NMA Reference Number: HREC/16/MonH/263
Monash Health HREC Ref: RES-16-0000-430A
SSA Reference Number: SSA/17/MonH/103
SEO Code - 920102 Cancer and Related Disorders
Effective start/end date3/12/1823/06/21